Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients



Rating:

Share or cite this content

Citations should be made in the following way:
S. Christopher (Vellore, India), R. Gupta (Vellore, India), B. Isaac (Vellore, India), D. Christopher (Vellore, India). Comparison of 3 prediction scores for diagnosis of Pulmonary Embolism. 492

Member's Comments

No comment yet.

Related content which might interest you: Prognostic scores in pulmonary embolism: PESI, simplified PESI or PREP? Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism Year: 2013 Improvements in risk stratification (RS): Beyond the pulmonary embolism severity index (PESI) score Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Comparison of Septic and Non-Septic Pulmonary Embolism in Children Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism Source: Eur Respir J 2013; 41: 354-359 Year: 2013 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Prognostic value of Mastora obstruction score in acute pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL) Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Pulmonary hypertension: diagnosis and classification Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009 Clinical significance of C reactive protein and MASTORA score in pulmonary embolism Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Acute Pulmonary Embolism in COPD patients, clinical features and outcomes Source: International Congress 2017 – Pulmonary embolism Year: 2017 Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Clinical phenotypes in pulmonary emboli identified by cluster analysis Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Pulmonary Embolism Source: Breathe, 15 (4) 360; 10.1183/20734735.ELF154 Year: 2019 Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 A combination of the Wells score with multiorgan ultrasound to stratify patients with suspected pulmonary embolism Source: International Congress 2015 – Chest ultrasonography: an imaging modality with hidden features Year: 2015 Predictors of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: results from a prospective cohort study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020